GSE69900
AE9aId1fl/flCreER cells
AE9aId1fl/flCreER cells treated with the control vehicle, CBD or 4-OHT Overall design: We treated AE9aId1fl/flCreER leukemia with 0.1 µM 4-hydroxytamoxifen (4-OHT) for 48 hours or the Id1 inhibitor CBD (at 15 µM) for 16 hours, and isolated RNA for RNA-seq analysis.